Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of Gemcitabine, Oxaliplatin and
Erlotinib in the treatment of patients with pancreatic cancer will provide increased clinical
benefits and improvement in their quality of life.